The Investment Miracle That Wasn’t The secret to investment success? Show up. John Rekenthaler May 10, 2018
Reader Mailbag: Future of Advice, Earnings John Rekenthaler tackles reader questions from his recent columns. John Rekenthaler May 4, 2018
How Financial Advice Should Work Two tiers of advisor, sorted by education (rather than ethics). John Rekenthaler May 1, 2018
Many Bubbles, Few Troubles As with forecast recessions, several bubbles are proclaimed for each that arrives. John Rekenthaler Apr 27, 2018
Why Annuities Belong in 401(k) Plans Easing the pain of achieving guaranteed income. John Rekenthaler Apr 25, 2018
Wrong Again: Mutual Fund Conspiracy Theories The industry is boring, but not dangerous. John Rekenthaler Apr 20, 2018
The Benefits of Investing Simply Keeping it easy can be surprisingly hard to do. John Rekenthaler Apr 17, 2018
Making Sense of Messy Funds The task is becoming easier, thanks to a Morningstar enhancement. John Rekenthaler Apr 13, 2018
Should All Investment Advice Be in the Customer's Best Interest? The ongoing controversy about a financial advisor's responsibilities. John Rekenthaler Apr 11, 2018
Why Buy Annuities? Two primary reasons: group insurance and longevity protection. John Rekenthaler Apr 6, 2018
Making Annuities More Attractive A good investment idea, badly marketed. John Rekenthaler Apr 3, 2018
How Long Can a Good Fund Underperform Its Benchmark? The challenge of distinguishing between skill and luck. John Rekenthaler Mar 26, 2018
2 Legal Decisions Affecting Mutual Funds The subjects--fees and fiduciary duties. John Rekenthaler Mar 20, 2018
Revenue Share: The Fund Industry's Dinosaur Eventually, it will become extinct. John Rekenthaler Mar 14, 2018
The Individual Investor's Edge Sometimes, it's not best to take a penny for one's thoughts. John Rekenthaler Mar 9, 2018
Trade Wars and Tariffs What might the steel and aluminum tariffs portend? John Rekenthaler Mar 7, 2018
The More Stocks, the Merrier On average, broadly diversified funds have outperformed concentrated funds. John Rekenthaler Mar 2, 2018
The Case for (and Against) Concentrated Funds Walking Through the Argument From GMO’s Ben Inker John Rekenthaler Feb 27, 2018